Worldwide Spending on Cancer Drugs Hits $100 Billion
/https://static.texastribune.org/media/images/Chemo-Machine.jpg)
Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up slightly more than 10 percent since 2013. (Modern Healthcare)